Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$1.06 - $2.33 $586 - $1,288
553 Added 0.9%
62,077 $67,000
Q2 2023

Aug 14, 2023

SELL
$2.15 - $3.49 $4,818 - $7,821
-2,241 Reduced 3.51%
61,524 $140,000
Q1 2023

May 15, 2023

SELL
$1.99 - $2.68 $14,085 - $18,969
-7,078 Reduced 9.99%
63,765 $154,000
Q4 2022

Feb 14, 2023

SELL
$1.8 - $2.56 $7,639 - $10,864
-4,244 Reduced 5.65%
70,843 $135,000
Q3 2022

Nov 14, 2022

BUY
$1.94 - $3.43 $117,406 - $207,580
60,519 Added 415.42%
75,087 $180,000
Q2 2022

Aug 15, 2022

SELL
$1.31 - $2.69 $95,933 - $196,994
-73,232 Reduced 83.41%
14,568 $27,000
Q1 2022

May 13, 2022

SELL
$1.95 - $3.89 $135,915 - $271,133
-69,700 Reduced 44.25%
87,800 $183,000
Q4 2021

Feb 11, 2022

SELL
$3.81 - $6.16 $6,477 - $10,472
-1,700 Reduced 1.07%
157,500 $621,000
Q3 2021

Nov 12, 2021

BUY
$3.38 - $5.35 $18,590 - $29,424
5,500 Added 3.58%
159,200 $766,000
Q2 2021

Aug 12, 2021

BUY
$4.12 - $5.87 $408,292 - $581,717
99,100 Added 181.5%
153,700 $705,000
Q1 2021

May 17, 2021

BUY
$3.45 - $9.09 $188,370 - $496,314
54,600 New
54,600 $321,000
Q3 2020

Nov 16, 2020

SELL
$1.44 - $2.1 $92,160 - $134,400
-64,000 Closed
0 $0
Q1 2020

May 06, 2020

BUY
$1.8 - $4.28 $8,640 - $20,544
4,800 Added 8.11%
64,000 $125,000
Q2 2019

Aug 14, 2019

BUY
$5.35 - $7.11 $6,954 - $9,243
1,300 Added 2.25%
59,200 $372,000
Q1 2019

May 13, 2019

BUY
$4.36 - $7.94 $57,988 - $105,602
13,300 Added 29.82%
57,900 $322,000
Q4 2018

Feb 11, 2019

BUY
$6.15 - $10.51 $83,640 - $142,936
13,600 Added 43.87%
44,600 $296,000
Q3 2018

Nov 14, 2018

SELL
$10.32 - $13.06 $951,049 - $1.2 Million
-92,156 Reduced 74.83%
31,000 $331,000
Q2 2018

Aug 03, 2018

SELL
$7.8 - $13.69 $361,140 - $633,847
-46,300 Reduced 27.32%
123,156 $1.48 Million
Q1 2018

May 07, 2018

BUY
$7.86 - $11.39 $1.09 Million - $1.58 Million
138,456 Added 446.63%
169,456 $1.45 Million
Q3 2017

Nov 01, 2017

BUY
$12.17 - $16.3 $377,270 - $505,300
31,000
31,000 $381,000

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $302M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.